Xenetic Biosciences, Inc.
XBIO
$3.02
-$0.12-3.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -25.38% | 74.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -25.38% | 74.10% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -25.38% | 74.10% | |||
| SG&A Expenses | -24.45% | 23.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.61% | 19.58% | |||
| Operating Income | -14.37% | 24.81% | |||
| Income Before Tax | -13.57% | 25.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.57% | 25.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.57% | 25.96% | |||
| EBIT | -14.37% | 24.81% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 19.69% | 25.95% | |||
| Normalized Basic EPS | 19.69% | 25.94% | |||
| EPS Diluted | 19.69% | 25.95% | |||
| Normalized Diluted EPS | 19.69% | 25.94% | |||
| Average Basic Shares Outstanding | 41.36% | 0.00% | |||
| Average Diluted Shares Outstanding | 41.36% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||